المؤلفون: Quinn Grundy (489976), Daphne Imahori (14374446), Shreya Mahajan (14374449), Gord Garner (9921756), Roberta Timothy (14374452), Abhimanyu Sud (8687670), Sophie Soklaridis (732072), Daniel Z. Buchman (14374455)

مصطلحات موضوعية: Pharmacology, Biotechnology, Science Policy, Mental Health, harm reduction related, following three ways, least one author, author disclosure statement, useful case study, preclinical animal studies, evidence base available, sponsoring research related, 59 %) participants, oriented research agendas, canadian cannabis company, canadian cannabis companies, included 156 articles, research study, research agendas, scientific evidence, human participants, empirical studies, cannabis company, cannabis companies, company name, biomedical companies, 90 %), 37 %), author conflicts, scientific research

Relation: https://figshare.com/articles/journal_contribution/Coding_manual_/21860517

الاتاحة: https://doi.org/10.1371/journal.pone.0280110.s004

المؤلفون: Quinn Grundy (489976), Daphne Imahori (14374446), Shreya Mahajan (14374449), Gord Garner (9921756), Roberta Timothy (14374452), Abhimanyu Sud (8687670), Sophie Soklaridis (732072), Daniel Z. Buchman (14374455)

مصطلحات موضوعية: Pharmacology, Biotechnology, Science Policy, Mental Health, harm reduction related, following three ways, least one author, author disclosure statement, useful case study, preclinical animal studies, evidence base available, sponsoring research related, 59 %) participants, oriented research agendas, canadian cannabis company, canadian cannabis companies, included 156 articles, research study, research agendas, scientific evidence, human participants, empirical studies, cannabis company, cannabis companies, company name, biomedical companies, 90 %), 37 %), author conflicts, scientific research

Relation: https://figshare.com/articles/journal_contribution/Sampling_and_search_strategies_/21860511

الاتاحة: https://doi.org/10.1371/journal.pone.0280110.s002

المؤلفون: Quinn Grundy (489976), Daphne Imahori (14374446), Shreya Mahajan (14374449), Gord Garner (9921756), Roberta Timothy (14374452), Abhimanyu Sud (8687670), Sophie Soklaridis (732072), Daniel Z. Buchman (14374455)

مصطلحات موضوعية: Pharmacology, Biotechnology, Science Policy, Mental Health, harm reduction related, following three ways, least one author, author disclosure statement, useful case study, preclinical animal studies, evidence base available, sponsoring research related, 59 %) participants, oriented research agendas, canadian cannabis company, canadian cannabis companies, included 156 articles, research study, research agendas, scientific evidence, human participants, empirical studies, cannabis company, cannabis companies, company name, biomedical companies, 90 %), 37 %), author conflicts, scientific research

Relation: https://figshare.com/articles/journal_contribution/List_of_PubMed_searches_/21860514

الاتاحة: https://doi.org/10.1371/journal.pone.0280110.s003

المؤلفون: Quinn Grundy (489976), Daphne Imahori (14374446), Shreya Mahajan (14374449), Gord Garner (9921756), Roberta Timothy (14374452), Abhimanyu Sud (8687670), Sophie Soklaridis (732072), Daniel Z. Buchman (14374455)

مصطلحات موضوعية: Pharmacology, Biotechnology, Science Policy, Mental Health, harm reduction related, following three ways, least one author, author disclosure statement, useful case study, preclinical animal studies, evidence base available, sponsoring research related, 59 %) participants, oriented research agendas, canadian cannabis company, canadian cannabis companies, included 156 articles, research study, research agendas, scientific evidence, human participants, empirical studies, cannabis company, cannabis companies, company name, biomedical companies, 90 %), 37 %), author conflicts, scientific research

Relation: https://figshare.com/articles/journal_contribution/STROBE_reporting_checklist_for_cross_sectional_studies_/21860508

الاتاحة: https://doi.org/10.1371/journal.pone.0280110.s001

المؤلفون: Quinn Grundy (489976), Daphne Imahori (14374446), Shreya Mahajan (14374449), Gord Garner (9921756), Roberta Timothy (14374452), Abhimanyu Sud (8687670), Sophie Soklaridis (732072), Daniel Z. Buchman (14374455)

مصطلحات موضوعية: Pharmacology, Biotechnology, Science Policy, Mental Health, harm reduction related, following three ways, least one author, author disclosure statement, useful case study, preclinical animal studies, evidence base available, sponsoring research related, 59 %) participants, oriented research agendas, canadian cannabis company, canadian cannabis companies, included 156 articles, research study, research agendas, scientific evidence, human participants, empirical studies, cannabis company, cannabis companies, company name, biomedical companies, 90 %), 37 %), author conflicts, scientific research

Relation: https://figshare.com/articles/dataset/S1_Dataset_-/21860520

الاتاحة: https://doi.org/10.1371/journal.pone.0280110.s005

المؤلفون: Quinn Grundy (489976), Daphne Imahori (14374446), Shreya Mahajan (14374449), Gord Garner (9921756), Roberta Timothy (14374452), Abhimanyu Sud (8687670), Sophie Soklaridis (732072), Daniel Z. Buchman (14374455)

مصطلحات موضوعية: Pharmacology, Biotechnology, Science Policy, Mental Health, harm reduction related, following three ways, least one author, author disclosure statement, useful case study, preclinical animal studies, evidence base available, sponsoring research related, 59 %) participants, oriented research agendas, canadian cannabis company, canadian cannabis companies, included 156 articles, research study, research agendas, scientific evidence, human participants, empirical studies, cannabis company, cannabis companies, company name, biomedical companies, 90 %), 37 %), author conflicts, scientific research

Relation: https://figshare.com/articles/figure/Study_identification_and_sampling_flow_diagram_/21860523

الاتاحة: https://doi.org/10.1371/journal.pone.0280110.g001

المؤلفون: Quinn Grundy (489976), Daphne Imahori (14374446), Shreya Mahajan (14374449), Gord Garner (9921756), Roberta Timothy (14374452), Abhimanyu Sud (8687670), Sophie Soklaridis (732072), Daniel Z. Buchman (14374455)

مصطلحات موضوعية: Pharmacology, Biotechnology, Science Policy, Mental Health, harm reduction related, following three ways, least one author, author disclosure statement, useful case study, preclinical animal studies, evidence base available, sponsoring research related, 59 %) participants, oriented research agendas, canadian cannabis company, canadian cannabis companies, included 156 articles, research study, research agendas, scientific evidence, human participants, empirical studies, cannabis company, cannabis companies, company name, biomedical companies, 90 %), 37 %), author conflicts, scientific research

Relation: https://figshare.com/articles/dataset/Article_characteristics_overall_and_by_type_of_cannabis-company_relationship_/21860526

الاتاحة: https://doi.org/10.1371/journal.pone.0280110.t001

المؤلفون: Quinn Grundy (489976), Daphne Imahori (14374446), Shreya Mahajan (14374449), Gord Garner (9921756), Roberta Timothy (14374452), Abhimanyu Sud (8687670), Sophie Soklaridis (732072), Daniel Z. Buchman (14374455)

مصطلحات موضوعية: Pharmacology, Biotechnology, Science Policy, Mental Health, harm reduction related, following three ways, least one author, author disclosure statement, useful case study, preclinical animal studies, evidence base available, sponsoring research related, 59 %) participants, oriented research agendas, canadian cannabis company, canadian cannabis companies, included 156 articles, research study, research agendas, scientific evidence, human participants, empirical studies, cannabis company, cannabis companies, company name, biomedical companies, 90 %), 37 %), author conflicts, scientific research

Relation: https://figshare.com/articles/dataset/Content_focus_of_cannabis-focused_articles_n_72_/21860529

الاتاحة: https://doi.org/10.1371/journal.pone.0280110.t002

المؤلفون: Quinn Grundy (489976), Daphne Imahori (14374446), Shreya Mahajan (14374449), Gord Garner (9921756), Roberta Timothy (14374452), Abhimanyu Sud (8687670), Sophie Soklaridis (732072), Daniel Z. Buchman (14374455)

مصطلحات موضوعية: Pharmacology, Biotechnology, Science Policy, Mental Health, harm reduction related, following three ways, least one author, author disclosure statement, useful case study, preclinical animal studies, evidence base available, sponsoring research related, 59 %) participants, oriented research agendas, canadian cannabis company, canadian cannabis companies, included 156 articles, research study, research agendas, scientific evidence, human participants, empirical studies, cannabis company, cannabis companies, company name, biomedical companies, 90 %), 37 %), author conflicts, scientific research

Relation: https://figshare.com/articles/dataset/Demographic_reporting_and_inclusion_in_empirical_studies_with_human_participants_/21860532

الاتاحة: https://doi.org/10.1371/journal.pone.0280110.t003

المؤلفون: Christopher B. Kaelin, Lijie Gong, Allison Wanting Xu, Fayi Yao, Kristin Hockman, Gregory J. Morton, Michael W. Schwartz, Gregory S. Barsh, Robert G. Mackenzie

المساهمون: The Pennsylvania State University CiteSeerX Archives

المصدر: http://mend.endojournals.org/cgi/rapidpdf/me.2006-0107v1.pdf.

مصطلحات موضوعية: Obesity, Agrp, Stat3, Leptin Author Disclosure Statement, The authors have nothing to declare. 1

وصف الملف: application/pdf

Relation: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.105.5336; http://mend.endojournals.org/cgi/rapidpdf/me.2006-0107v1.pdf

الاتاحة: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.105.5336
http://mend.endojournals.org/cgi/rapidpdf/me.2006-0107v1.pdf